MedPath

江西东风药业股份有限公司

Ownership
-
Established
2002-04-25
Employees
-
Market Cap
-
Website
http://www.jxdfyy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

99

NMPA:99

Drug Approvals

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H36020225
Approval Date
Jul 18, 2022
NMPA

Cefotaxime Sodium for Injection

Product Name
注射用头孢噻肟钠
Approval Number
国药准字H20044594
Approval Date
Jul 17, 2022
NMPA

Ceftriaxone Sodium for Injection

Product Name
注射用头孢曲松钠
Approval Number
国药准字H20044746
Approval Date
Jul 17, 2022
NMPA

Cefotaxime Sodium for Injection

Product Name
注射用头孢噻肟钠
Approval Number
国药准字H20044595
Approval Date
Jul 17, 2022
NMPA

Cefoperazone Sodium and Sulbactam Sodium for Injection

Product Name
注射用头孢哌酮钠舒巴坦钠
Approval Number
国药准字H20044013
Approval Date
Jul 17, 2022
NMPA

Cefoperazone Sodium and Sulbactam Sodium for Injection

Product Name
注射用头孢哌酮钠舒巴坦钠
Approval Number
国药准字H20044014
Approval Date
Jul 17, 2022
NMPA

Ceftriaxone Sodium for Injection

Product Name
注射用头孢曲松钠
Approval Number
国药准字H20044745
Approval Date
Jul 17, 2022
NMPA

Cefotaxime Sodium for Injection

Product Name
注射用头孢噻肟钠
Approval Number
国药准字H20033364
Approval Date
Jul 17, 2022
NMPA

Benzylpenicillin Sodium for Injection

Product Name
注射用青霉素钠
Approval Number
国药准字H36020262
Approval Date
Jul 17, 2022
NMPA

Benzylpenicillin Potassium for Injection

Product Name
注射用青霉素钾
Approval Number
国药准字H36020253
Approval Date
Jul 17, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.